These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24771499)

  • 1. The impact of induction therapy on the homeostasis and function of regulatory T cells in kidney transplant patients.
    Bouvy AP; Klepper M; Kho MM; Boer K; Betjes MG; Weimar W; Baan CC
    Nephrol Dial Transplant; 2014 Aug; 29(8):1587-97. PubMed ID: 24771499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of homeostatic proliferation and thymopoiesis after rATG induction therapy in kidney transplant patients.
    Bouvy AP; Kho MM; Klepper M; Litjens NH; Betjes MG; Weimar W; Baan CC
    Transplantation; 2013 Nov; 96(10):904-13. PubMed ID: 23985721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
    Krystufkova E; Sekerkova A; Striz I; Brabcova I; Girmanova E; Viklicky O
    Nephrol Dial Transplant; 2012 Jun; 27(6):2576-82. PubMed ID: 22167587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation.
    Pilch NA; Taber DJ; Moussa O; Thomas B; Denmark S; Meadows HB; McGillicuddy JW; Srinivas TR; Baliga PK; Chavin KD
    Ann Surg; 2014 May; 259(5):888-93. PubMed ID: 24513787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of induction therapy on the expression of molecular markers associated with rejection and tolerance.
    Krepsova E; Tycova I; Sekerkova A; Wohlfahrt P; Hruba P; Striz I; Sawitzki B; Viklicky O
    BMC Nephrol; 2015 Aug; 16():146. PubMed ID: 26286066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study.
    Gentile G; Somma C; Gennarini A; Mastroluca D; Rota G; Lacanna F; Locatelli B; Remuzzi G; Ruggenenti P
    Am J Nephrol; 2015; 41(1):16-27. PubMed ID: 25612603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of suppressive allogeneic regulatory T cells via rabbit antithymocyte polyclonal globulin during homeostatic proliferation in rat kidney transplantation.
    Valdez-Ortiz R; Bestard O; Llaudó I; Franquesa M; Cerezo G; Torras J; Herrero-Fresneda I; Correa-Rotter R; Grinyó JM
    Transpl Int; 2015 Jan; 28(1):108-19. PubMed ID: 25208307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of bona fide regulatory T cells after liver transplantation - the potential influence of polyclonal antithymocyte globulin.
    Stauch D; Yahyazadeh A; Bova R; Melloh GC; Füldner A; Baron U; Olek S; Göldner K; Weiss S; Pratschke J; Kotsch K
    Transpl Int; 2012 Mar; 25(3):302-13. PubMed ID: 22188119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of terminal complement blockade on the efficacy of induction with polyclonal rabbit antithymocyte globulin in living donor renal allografts.
    Goh BK; Chedid MF; Gloor JM; Raghavaiah S; Stegall MD
    Transpl Immunol; 2012 Oct; 27(2-3):95-100. PubMed ID: 22813834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report.
    Zhao T; Yang C; Xue Y; Qiu YY; Hu L; Qiu Y; Wang X; Yang B; Rong R; Xu M; Zhu T
    Transplant Proc; 2012 Jan; 44(1):175-8. PubMed ID: 22310608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.
    Lentine KL; Schnitzler MA; Xiao H; Brennan DC
    Trials; 2015 Aug; 16():365. PubMed ID: 26285695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.
    Flaman F; Zieroth S; Rao V; Ross H; Delgado DH
    J Heart Lung Transplant; 2006 Nov; 25(11):1358-62. PubMed ID: 17097501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.
    Laftavi MR; Alnimri M; Weber-Shrikant E; Kohli R; Said M; Patel S; Pankewycz O
    Transplant Proc; 2011 Mar; 43(2):458-61. PubMed ID: 21440733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection.
    Deeks ED; Keating GM
    Drugs; 2009 Jul; 69(11):1483-512. PubMed ID: 19634926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial.
    Carrier M; Leblanc MH; Perrault LP; White M; Doyle D; Beaudoin D; Guertin MC
    J Heart Lung Transplant; 2007 Mar; 26(3):258-63. PubMed ID: 17346628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE; Weng RR; Piper M; Laugenou K; Ichii H; Lakey J; Malinoski D
    Transplant Proc; 2012 Jan; 44(1):164-6. PubMed ID: 22310605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.
    Sewgobind VD; Kho MM; van der Laan LJ; Hendrikx TK; van Dam T; Tilanus HW; IJzermans JN; Weimar W; Baan CC
    Nephrol Dial Transplant; 2009 May; 24(5):1635-44. PubMed ID: 19176684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience.
    Huang HF; Zhou JY; Xie WQ; Wu JY; Deng H; Chen JH
    Int Urol Nephrol; 2016 Aug; 48(8):1363-1370. PubMed ID: 27170340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
    Brennan DC; Daller JA; Lake KD; Cibrik D; Del Castillo D;
    N Engl J Med; 2006 Nov; 355(19):1967-77. PubMed ID: 17093248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction therapy in renal transplant recipients: how convincing is the current evidence?
    Wagner SJ; Brennan DC
    Drugs; 2012 Mar; 72(5):671-83. PubMed ID: 22439670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.